References
- Challa, B.R., Awen B.Z., Chandu, B.R., Khagga, M., Kotthapalli, CB., 2010. Method development and validation of montelukast in human plasma by HPLC coupled with ESI-MS/ MS: Application to a bioequivalence study. Sci Pharm. 78(3), 411-422. https://doi.org/10.3797/scipharm.1002-07
- Sripalakit, P., Kongthong, B., Saraphanchotiwitthaya, A., 2008. A simple bioanalytical assay for determination of montelukast in human plasma: application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 869(1-2), 38-44. https://doi.org/10.1016/j.jchromb.2008.05.017
- Mastalerz, L., Kumik, J., 2010. Antileukotriene drugs in the treatment of asthma. Pol Arch Med Wewn. 120(3), 103-108.
- Castro-Rodriguez, J.A., Rodrigo, G.J., 2010. The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma: results of a systematic review with meta-analysis. Arch Dis Child. 95(5), 365-370. https://doi.org/10.1136/adc.2009.169177
- Yasar, H., Kiran, B., Cagatay, T., Ozkul, H., Icten, S., 2011. The effect of montelukast sodium on serum arginase levels in patients with seasonal allergic rhinitis. Am J Rhinol Allergy.
- Schaper, C., Noga, O., Koch, B., Ewert, R., Felix, S.B., Gläser S., Kunkel, G., Gustavus B., 2011. Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis. J Investig Allergol Clin Immunol. 21(1), 51-58.
- Amin, R.D., Cheng, H., Rogers, J.D., 1995. Determination of MK- 0476 in human plasma by liquid chromatography. J Pharm Biomed Anal. 13(2), 155-158. https://doi.org/10.1016/0731-7085(94)00138-R
- Liu, L., Cheng, H., Zhao, J.J., Rogers, J.D., 1997. Determination of montelukast (MK-0476) and its S-enantiomer in human plasma by stereoselective high-performance liquid chromatography with column-switching. J Pharm Biomed Anal. 15(5), 631-638. https://doi.org/10.1016/S0731-7085(96)01894-8
- Al-Rawithi, S., Al-Gazlan, S., Al-Ahmadi, W., Alshowaier, IA., Yusuf, A., Raines, D.A., 2011. Expedient liquid chromatographic method with fluorescence detection for montelukast sodium in micro-samples of plasma. J Chromatogr B Biomed Sci. 754(2), 527-531.
- Smith, G.A., Rawls, C.M., Kunka, R.L., 2004. An automated method for the determination of montelukast in human plasma using dual-column HPLC analysis and peak height summation of the parent compound and its photodegradation product. Pharm Res. 21(9), 1539-1544. https://doi.org/10.1023/B:PHAM.0000041445.76931.27
- Bharathi, D.V., Hotha, K.K., Jagadeesh, B., Mullangi, R., Naidu, A., 2009. Quantification of montelukast, a selective cysteinyl leukotriene receptor (CysLT1) antagonist in human plasma by liquid chromatography-mass spectrometry: validation and its application to a human pharmacokinetic study. Biomed Chromatogr. 23(8), 804-810. https://doi.org/10.1002/bmc.1189
- Cheng, H., Leff, J.A., Amin, R., Gertz, B.J., De Smet, M., Noonan, N., Rogers, J.D., Malbecq, W., Meisner, D. Somers, G., 1996. Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females. Pharmaceutical Research. 13, 445-448. https://doi.org/10.1023/A:1016056912698
- Ochiai, H., Uchiyama, N., Takano, T., Hara, K., Kamei, T., 1998. Determination of montelukast sodium in human plasma by column-switching high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl. 713(2), 409-414. https://doi.org/10.1016/S0378-4347(98)00179-0
- Alsarra, I., Khalil, NY., Sultan, M., Al-Ashban, R., Belal, F., 2005. Spectrofluorometric determination of montelukast in dosage forms and spiked human plasma. Pharmazie. 60(11), 823-826.
- Al Omari, M.M., Zoubi, R.M., Hasan, E.I., Khader, T.Z., Badwan, A.A., 2007. Effect of light and heat on the stability of montelukast in solution and in its solid state. J Pharm Biomed Anal. 45(3), 465-471. https://doi.org/10.1016/j.jpba.2007.07.014
- Korea FDA, 2003 Guideline for the Validation of Bioanalytical Method 2003.05.